Hygieia Extends Series B Round to $22 Million with Participation from Strategic Investors

[#item_full_content]LIVONIA, Mich.–(BUSINESS WIRE)– #diabetes–Hygieia, a digital therapeutics company for insulin therapy, is extending its Series B funding round to $22 million with investment from 3 partners.